177 related articles for article (PubMed ID: 23359562)
1. The autoimmunity risk variant LYP-W620 cooperates with CSK in the regulation of TCR signaling.
de la Puerta ML; Trinidad AG; Rodríguez Mdel C; de Pereda JM; Sánchez Crespo M; Bayón Y; Alonso A
PLoS One; 2013; 8(1):e54569. PubMed ID: 23359562
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue.
Fiorillo E; Orrú V; Stanford SM; Liu Y; Salek M; Rapini N; Schenone AD; Saccucci P; Delogu LG; Angelini F; Manca Bitti ML; Schmedt C; Chan AC; Acuto O; Bottini N
J Biol Chem; 2010 Aug; 285(34):26506-18. PubMed ID: 20538612
[TBL] [Abstract][Full Text] [Related]
3. LYP inhibits T-cell activation when dissociated from CSK.
Vang T; Liu WH; Delacroix L; Wu S; Vasile S; Dahl R; Yang L; Musumeci L; Francis D; Landskron J; Tasken K; Tremblay ML; Lie BA; Page R; Mustelin T; Rahmouni S; Rickert RC; Tautz L
Nat Chem Biol; 2012 Mar; 8(5):437-46. PubMed ID: 22426112
[TBL] [Abstract][Full Text] [Related]
4. The autoimmune-predisposing variant of lymphoid tyrosine phosphatase favors T helper 1 responses.
Vang T; Landskron J; Viken MK; Oberprieler N; Torgersen KM; Mustelin T; Tasken K; Tautz L; Rickert RC; Lie BA
Hum Immunol; 2013 May; 74(5):574-85. PubMed ID: 23333624
[TBL] [Abstract][Full Text] [Related]
5. Autoimmunity-associated LYP-W620 does not impair thymic negative selection of autoreactive T cells.
Wu DJ; Zhou W; Enouz S; Orrú V; Stanford SM; Maine CJ; Rapini N; Sawatzke K; Engel I; Fiorillo E; Sherman LA; Kronenberg M; Zehn D; Peterson E; Bottini N
PLoS One; 2014; 9(2):e86677. PubMed ID: 24498279
[TBL] [Abstract][Full Text] [Related]
6. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase.
Cloutier JF; Veillette A
J Exp Med; 1999 Jan; 189(1):111-21. PubMed ID: 9874568
[TBL] [Abstract][Full Text] [Related]
7. A weak Lck tail bite is necessary for Lck function in T cell antigen receptor signaling.
Nika K; Tautz L; Arimura Y; Vang T; Williams S; Mustelin T
J Biol Chem; 2007 Dec; 282(49):36000-9. PubMed ID: 17897955
[TBL] [Abstract][Full Text] [Related]
8. CD45-Csk phosphatase-kinase titration uncouples basal and inducible T cell receptor signaling during thymic development.
Zikherman J; Jenne C; Watson S; Doan K; Raschke W; Goodnow CC; Weiss A
Immunity; 2010 Mar; 32(3):342-54. PubMed ID: 20346773
[TBL] [Abstract][Full Text] [Related]
9. Lymphoid-specific tyrosine phosphatase (Lyp): a potential drug target for treatment of autoimmune diseases.
Du J; Qiao Y; Sun L; Wang X
Curr Drug Targets; 2014 Mar; 15(3):335-46. PubMed ID: 24188455
[TBL] [Abstract][Full Text] [Related]
10. PTPN22 phosphorylation acts as a molecular rheostat for the inhibition of TCR signaling.
Yang S; Svensson MND; Harder NHO; Hsieh WC; Santelli E; Kiosses WB; Moresco JJ; Yates JR; King CC; Liu L; Stanford SM; Bottini N
Sci Signal; 2020 Mar; 13(623):. PubMed ID: 32184287
[TBL] [Abstract][Full Text] [Related]
11. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
Wang B; Lemay S; Tsai S; Veillette A
Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
[TBL] [Abstract][Full Text] [Related]
12. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells.
Frearson JA; Alexander DR
J Exp Med; 1998 May; 187(9):1417-26. PubMed ID: 9565634
[TBL] [Abstract][Full Text] [Related]
13. Novel tools to dissect the dynamic regulation of TCR signaling by the kinase Csk and the phosphatase CD45.
Tan YX; Zikherman J; Weiss A
Cold Spring Harb Symp Quant Biol; 2013; 78():131-139. PubMed ID: 24100586
[TBL] [Abstract][Full Text] [Related]
14. CSK associates with the TCR zeta and epsilon chains via its SH2 domain; a mechanism for turning off TCR signaling.
Catipović B
Lijec Vjesn; 1996; 118(11-12):264-71. PubMed ID: 9172452
[TBL] [Abstract][Full Text] [Related]
15. Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.
Yu X; Sun JP; He Y; Guo X; Liu S; Zhou B; Hudmon A; Zhang ZY
Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19767-72. PubMed ID: 18056643
[TBL] [Abstract][Full Text] [Related]
16. Leukocyte-associated immunoglobulin-like receptor 1 inhibits T-cell signaling by decreasing protein phosphorylation in the T-cell signaling pathway.
Park JE; Brand DD; Rosloniec EF; Yi AK; Stuart JM; Kang AH; Myers LK
J Biol Chem; 2020 Feb; 295(8):2239-2247. PubMed ID: 31932281
[TBL] [Abstract][Full Text] [Related]
17. Csk is constitutively associated with a 60-kDa tyrosine-phosphorylated protein in human T cells.
Catipović B; Schneck JP; Brummet ME; Marsh DG; Rafnar T
J Biol Chem; 1996 Apr; 271(16):9698-703. PubMed ID: 8621646
[TBL] [Abstract][Full Text] [Related]
18. Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells.
Cloutier JF; Veillette A
EMBO J; 1996 Sep; 15(18):4909-18. PubMed ID: 8890164
[TBL] [Abstract][Full Text] [Related]
19. Feedback circuits monitor and adjust basal Lck-dependent events in T cell receptor signaling.
Schoenborn JR; Tan YX; Zhang C; Shokat KM; Weiss A
Sci Signal; 2011 Sep; 4(190):ra59. PubMed ID: 21917715
[TBL] [Abstract][Full Text] [Related]
20. Combined spatial and enzymatic regulation of Csk by cAMP and protein kinase a inhibits T cell receptor signaling.
Vang T; Abrahamsen H; Myklebust S; Horejsí V; Taskén K
J Biol Chem; 2003 May; 278(20):17597-600. PubMed ID: 12665526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
